Pfizer gets FDA approval for Xalkori to treat ALK-positive lymphoma
Xalkori is a tyrosine kinase inhibitor (TKI), which treats ALK- or ROS1-positive metastatic NSCLC tumours, as detected by…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jan 21
Xalkori is a tyrosine kinase inhibitor (TKI), which treats ALK- or ROS1-positive metastatic NSCLC tumours, as detected by…
13 Jan 21
VIR-7832 is the second monoclonal antibody from Vir-GSK collaboration, and the study is expected to commence in Q1…
11 Jan 21
The UK regulatory agency MHRA authorised the vaccine based on a rolling review of data, including data from…
07 Jan 21
EC authorisation follows European Medicines Agency recommendation and CHMP positive opinion for Moderna’s Covid-19 Vaccine
06 Jan 21
The US FDA’s break through designation is based on data from the Phase 2 CITYSCAPE trial of tiragolumab…
05 Jan 21
Israel’s Ministry of Health has secured six million doses of the Moderna Covid-19 vaccine, with initial supply expected…
04 Jan 21
Bharat Biotech's Covaxin has been approved for restricted use in emergency situation in public interest as an abundant…
30 Dec 20
If the discussions are fruitful, Moderna is expected to supply 40 million doses of mRNA-1273 vaccine in South…
29 Dec 20
The generic glucagon is a synthetic version of human glucagon, a hormone that causes the liver to increase…
24 Dec 20
The SC formulation of Perjeta and Herceptin with hyaluronidase was approved based on the results of the phase…